Coronary artery disease after menopause and the role of estrogen replacement therapy.

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Journal of Cardiovascular Medicine

• Publication date

  2018-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.2459/JCM.0000000000000596PMID 29538156
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Diagnosis and Management of Menopause: The National Institute of Health and Care Excellence (NICE) Guideline.

  2016cited by this paper
• Association of Age at Onset of Menopause and Time Since Onset of Menopause With Cardiovascular Outcomes, Intermediate Vascular Traits, and All-Cause Mortality: A Systematic Review and Meta-analysis.

  2016cited by this paper
• Revised global consensus statement on menopausal hormone therapy.

  2016cited by this paper
• Age at Menopause and Extent of Coronary Artery Disease Among Postmenopausal Women with Acute Coronary Syndromes.

  2016cited by this paper
• Cancer treatment and survivorship statistics, 2016

  2016cited by this paper
• Revised Global Consensus Statement on Menopausal Hormone Therapy

  2016cited by this paper
• Vascular Effects of Early versus Late Postmenopausal Treatment with Estradiol.

  2016cited by this paper
• Association between duration of reproductive lifespan and Framingham risk score in postmenopausal women.

  2015cited by this paper
• Menopausal Hormone Therapy for the Primary Prevention of Chronic Conditions: U.S. Preventive Services Task Force Recommendation Statement

  2013cited by this paper
• Age at Menopause, Reproductive Life Span, and Type 2 Diabetes Risk

  2013cited by this paper
• Cardiovascular disease in Europe 2014: epidemiological update.

  2013cited by this paper
• Effect of hormone replacement therapy on cardiovascular events in recently postmenopausal women: randomised trial

  2012cited by this paper
• Gender and the extent of coronary atherosclerosis, plaque composition, and clinical outcomes in acute coronary syndromes.

  2012cited by this paper
• Questioning the cardioprotective action of hormone replacement therapy in postmenopausal women.

  2009cited by this paper
• Heart disease risk determines menopausal age rather than the reverse.

  2006cited by this paper
• Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence.

  2004cited by this paper
• Effects of hormone replacement therapy and antioxidant vitamin supplements on coronary atherosclerosis in postmenopausal women. A randomized controlled trial

  2003cited by this paper
• Estrogen plus progestin and the risk of coronary heart disease.

  2003cited by this paper
• Hormone therapy and the progression of coronary-artery atherosclerosis in postmenopausal women.

  2003cited by this paper
• The protective effects of estrogen on the cardiovascular system.

  2002cited by this paper
• Effects of hormone replacement therapy and antioxidant vitamin supplements on coronary atherosclerosis in postmenopausal women: a randomized controlled trial.

  2002cited by this paper
• Estrogen in the prevention of atherosclerosis. A randomized, double-blind, placebo-controlled trial.

  2001cited by this paper
• Effect of menopause on plaque morphologic characteristics in coronary atherosclerosis.

  2001cited by this paper
• Effects of estrogen replacement on the progression of coronary-artery atherosclerosis.

  2000cited by this paper
• Age at natural menopause and risk of cardiovascular disease.

  1999cited by this paper
• Age at natural menopause and mortality.

  1998cited by this paper
• Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group.

  1998cited by this paper
• Age at menopause as a risk factor for cardiovascular mortality.

  1996cited by this paper
• Is early natural menopause a biologic marker of health and aging?

  1989cited by this paper

• Sex-related disparities in coronary artery disease in postmenopausal women-a global view and recommendations for the future.

  2025cites this paper
• European society of endocrinology clinical practice guideline for evaluation and management of menopause and the perimenopause.

  2025cites this paper
• Decreased Bone Mineral Density Is Associated with Subclinical Atherosclerosis in Asymptomatic Non-Diabetic Postmenopausal Women

  2025cites this paper
• Predictors of subclinical atherosclerosis in asymptomatic healthy non‐diabetic postmenopausal women

  2024cites this paper
• Coronary atherosclerosis in apparently healthy master athletes discovered during pre-PARTECIPATION screening. Role of coronary CT angiography (CCTA).

  2019cites this paper
• Estrogen levels and risk factors for coronary artery disease in elderly women

  2019cites this paper
• Theacrine attenuates myocardial fibrosis after myocardial infarction via the SIRT3/β-catenin/PPARγ pathway in estrogen-deficient mice.

  2019cites this paper